Evidence map›Paper›PMID 21474067›Full record

ArticleMolecular cell2011

Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size.

Abdelhafid Saci, Lewis C Cantley, Christopher L Carpenter

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 269 citations in OpenAlex.

  1. Review
  2. The role of mTORC2/RICTOR in immune cells and inflammatory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Article
  4. Article
  5. TNFAIP8L2 maintains hair cell function and regulates age-related hearing loss via mTORC1 signaling.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Mechanisms of Cell Fusion in Cancer.Results and problems in cell differentiation · 2024
    Review
  15. Article
  16. Article
  17. UsingCells · 2023
    Review
  18. Article
  19. Regulation of CD8Cellular & molecular immunology · 2023
    Review
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Abdelhafid SaciDepartment of Medicine, Division of Signal Transduction, Harvard Medical School, Beth Israel Deaconess Medical Center, CLS-417, Boston, MA 02115, USA. asaci@bidmc.harvard.edu
Lewis C Cantley
Christopher L Carpenter
Harvard University · USBeth Israel Deaconess Medical Center · US

Funding

Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
PROTEIN KINASE SIGNALING PATHWAYSR01GM056203 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CANTLEY, LEWIS C. · 1997 to 2012
$4.5M
The Role of PI3K in Growth RegulationR01GM041890 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CANTLEY, LEWIS C. · 1990 to 2016
$4.1M
The function of RhoBTB proteinsR01CA113559 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SOLTOFF, STEPHEN PAUL · 2006 to 2010
$1.5M
NCI NIH HHS 5R01 CA113559NCI NIH HHS P01 CA120964NCI NIH HHS R01 CA113559NIGMS NIH HHS R01 GM041890NIGMS NIH HHS R01 GM056203NIGMS NIH HHS R01 GM41890
6 · The paper itself

Abstract

Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that exists in two separate complexes, mTORC1 and mTORC2, that function to control cell size and growth in response to growth factors, nutrients, and cellular energy levels. Low molecular weight GTP-binding proteins of the Rheb and Rag families are key regulators of the mTORC1 complex, but regulation of mTORC2 is poorly understood. Here, we report that Rac1, a member of the Rho family of GTPases, is a critical regulator of both mTORC1 and mTORC2 in response to growth-factor stimulation. Deletion of Rac1 in primary cells using an inducible-Cre/Lox approach inhibits basal and growth-factor activation of both mTORC1 and mTORC2. Rac1 appears to bind directly to mTOR and to mediate mTORC1 and mTORC2 localization at specific membranes. Binding of Rac1 to mTOR does not depend on the GTP-bound state of Rac1, but on the integrity of its C-terminal domain. This function of Rac1 provides a means to regulate mTORC1 and mTORC2 simultaneously.

Indexed as

Cell SizeAnimalsCells, CulturedGuanosine DiphosphateGuanosine TriphosphateHumansMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MiceMice, KnockoutMultiprotein ComplexesNeuropeptidesPhosphatidylinositol 3-KinasesProtein BindingProteinsProto-Oncogene Proteins c-aktGuanosine DiphosphateGuanosine TriphosphateMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesNeuropeptidesPhosphatidylinositol 3-KinasesProteinsProto-Oncogene Proteins c-aktrac1 GTP-Binding ProteinRac1 protein, mouserac GTP-Binding ProteinsRNA, Small InterferingTOR Serine-Threonine Kinases

Identifiers

PMID21474067
PMCPMC3750737
OpenAlexW2059019158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.